| April 19, 2017 |
Webinar: Combining Target-Based and Phenotypic Discovery Assays for Drug Repurposing - 40 min.
What will be covered?
- Using phenotypic profiling to characterize clinically successful drugs for a given indication
- Combining target-based and phenotypic data to prioritize drugs for repurposing
- Understanding how multi-targeted kinases can be pivoted towards new indications
|
Login to view
|
Login to view
|
| October 26, 2016 |
Webinar: Target to Phenotype: Tools to Accelerate Your Immuno-Oncology Drug Pipeline - 60 min.
What will be covered?
- Challenges in immuno-oncology drug development
- Tools to expedite and simplify any immuno-oncology drug development pipeline
|
Login to view
|
Login to view
|
| September 30, 2016 |
Webinar: Immuno-Oncology Drug Development: Profiling Immunomodulatory Biologics and Compounds in Human Primary Cell-Based Oncology Models - 60 min.
What will be covered?
- Overview of the BioMAP® immuno-oncology/oncology systems
- Information BioMAP iOnc studies provide
- Host stromal/vascular - tumor microenvironment biology
- Case studies of profiling Ab therapies (anti-PD-1, anti-CTLA-4, etc.) and preclinical compounds
|
Login to view
|
Login to view
|
| August 10, 2016 |
Webinar: New Tricks for Old Drugs: An Unbiased Phenotypic Approach to Drug Repurposing - 40 min.
What will be covered?
- Overview of the BioMAP Diversity PLUS phenotypic screening platform's modeling of broad human tissue and disease biology
- Details of how Diversity PLUS profiling guides new indications for marketed drugs and pre-clinical candidates
- Examples highlighting how this technology is used to support repositioning of approved drugs for alternate indications
|
Login to view
|
Login to view
|
| April 22, 2016 |
BioMAP表現型プロファイリング：今まで見えなかった試験物質の一面を明瞭に - 60 min.
What will be covered?
-
Tofacitinibの様な抗炎症剤から、食材までの表現型解析例の紹介
-
臨床試験への架け橋となったデータの実施例
-
Skin Rash・Thrombosis等を明瞭に：BioMAPシステムの応用例
-
パワーアップした試験報告書のご紹介：さらに充実したデータのご提供
-
メカニズム探査によるリード化合物の毒性、薬理、安全性等の同定
|
Login to view
|
Login to view
|
| December 11, 2015 |
Introduction to BioMAP® Systems: Phenotypic drug profiling in human primary cell systems - 60 min.
What will be covered
-
How BioMAP systems creates a unique profile for your drug
-
Case studies using the screening technology platform
-
Applications for phenotypic drug discovery
-
Services offered for compound profiling
|
Login to view
|
Login to view
|
| November 6, 2015 |
被験化合物によるGi ToxやSkin Rash等を明瞭に：BioMAPシステムの応用例 - 60 min.
eSeminarの課題:
-
Gi Tox、Skin Rash等の応用実施例の紹介
-
リード化合物の選択や臨床標準治療との直接比較
-
メカニズム探査によるリード化合物の毒性、薬理、安全性等の同定
-
2016年度パネルスケジュール
|
Login to view
|
Login to view
|
| July 9, 2015 |
Profiling Immunomodulatory mAbs, Compounds and Combinations in Human Primary Cell-based Oncology Models - 30 min.
What will be covered
-
Overview of the BioMAP Immuno-Oncology/Oncology Systems
-
Host Stromal/Vascular - Tumor Microenvironment Biology
-
Inflammation/Immune Biology
-
Comparison to MLR (Mixed Lymphocyte Reaction) assays
-
Immunophenotypic analysis
-
Case studies of profiling Ab therapies (anti-PD-1, anti-CTLA-4, etc.) and preclinical compounds
-
Case studies of combination studiest
|
Login to view
|
Login to view
|
| April 1, 2015 |
BioMAP® Systems: Human Primary Cell Based Disease and Tissue Models for Drug Discovery - 40 min.
What will be covered?
-
Overview of BioMAP® Technology Platform
-
Case studies and applications of phenotypic screening in drug discovery
-
Services offered for compound profiling
|
Login to view
|
Login to view
|
| February 19, 2015 |
Human Primary Cell BioMAP® Systems for Drug Discovery - 60 min.
What will be covered?
-
Overview of the BioMAP systems
-
Case studies using the screening technology platform
-
Applications for phenotypic drug discovery
-
Services offered for compound profiling
|
Login to view
|
Login to view
|
| September 25, 2014 |
Analysis of α-PD-1, α-PD-L1 and Yervoy® (ipilimumab/α-CTLA-4) Immune Check Point Antibodies in Human Primary Cell BioMAP® Oncology Systems - 53 min.
What will be covered
-
Overview of the BioMAP Oncology Systems
-
Case studies of immune check point antibodies using the screening technology platform
-
Applications for phenotypic drug discovery and compound profiling
|
Login to view
|
Login to view
|
| July 31, 2014 |
BioMAP Webinar: Human Primary Cell BioMAP® Systems for Drug Discovery - 60 min.
What will be covered?
• Overview of the BioMAP systems
• Case studies using the screening technology platform
• Applications for phenotypic drug discovery
• Services offered for compound profiling
|
Login to view
|
Login to view
|
| August 14, 2013 |
BioMAP® Systems: Human Primary Cells Systems for Phenotypic Drug Discovery - 60 min.
What will be covered?
-
Overview of the BioMAP systems
-
Case studies using the screening technology platform
-
Applications for phenotypic drug discovery
-
Services offered for compound profiling
|
Login to view
|
Login to view
|
| July 26, 2013 |
Introduction to the BioMAP® Platform: Primary Human Cell Systems for Drug Discovery - 60 min.
What will be covered?
We will introduce the BioMAP Platform and present examples of how the primary human cell-based systems have provided insights into the drug discovery and development process, as well as enable biomarker discovery and validation. |
Login to view
|
Login to view
|
| February 14, 2013 |
Introduction to the BioMAP® Platform: Primary Human Cell Systems for Drug Discovery - 60 min.
What will be covered?
• Overview of the BioMAP system
• Case Studies using the platform
• Compound Profiling Services |
Login to view
|
Login to view
|